Shanghai INT Medical(01501.HK): Grant of 33,400 H-share Awards to Executive Director Liang Dongke

NewTimeSpace · 2026/06/30 08:55 · By Zeyu Wu

NewTimeSpace News: Shanghai INT Medicalannounced on June 29 that pursuant to the Company’s H-Share Incentive Trust Plan, the Board of Directors granted an aggregate of 33,400 H-share award shares to Dr. Liang Dongke, Executive Director, on June 28, 2026, at a subscription price of RMB 24.61 per share.

NewTimeSpace News: On June 29, 2026, Shanghai INT Medical(01501.HK) issued an announcement stating that the Board resolved to grant 33,400 H-share award shares to Dr. Liang Dongke, Chairman and Executive Director of the Company under the H-Share Incentive Trust Plan, with a subscription price of RMB 24.61 per share.

The awards shall vest in three tranches: 0% vesting upon the expiry of 12 months from the grant date, 30% vesting upon the expiry of 24 months, and 70% vesting upon the expiry of 36 months. Vesting of the awards is subject to the Company’s financial performance targets (revenue or net profit metrics) and the terms and conditions set out in the award letter.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

Tags：

Shanghai INT Medical 01501.HK